Najlepsi lekarze wykonujący MRI mózgu w Izraelu – TOP 9 lekarzy

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr Oren Shibolet jest doświadczonym gastroenterologiem i hematologiem z ponad 50-letnią praktyką. Jest wiodącym ekspertem w zakresie chorób wątroby i ich leczenia, pełniąc funkcję Kierownika Oddziału Chorób Wątroby w Centrum Medycznym Sourasky (Ichilov). Posiada dyplom z medycyny ogólnej Uniwersytetu Hebrajskiego, specjalizację z gastroenterologii z Wydziału Medycznego Uniwersytetu Hebrajskiego Hadassah i jest członkiem wielu organizacji medycznych. Jest również autorem ponad 60 publikacji i 100 raportów konferencyjnych.

• Edukacja
• 1992-1999 - Wydział Medycyny, Technion.
• Specjalizacja
• 2000-2005 - Staż w Instytucie Wizualizacji, Medyczne Centrum Tel Aviv Sourasky (Ichilov).
• Uznane doświadczenie
• Radiologia diagnostyczna
• Podspecjalizacja:
• 2005-2007 - Obrazowanie piersi, Instytut Mammografii, Centrum Medyczne Tel Aviv.
• Dodatkowa edukacja
• 2008 - Rezonans magnetyczny gruczołu piersiowego, staż w Centrum Medycznym Instytutu Curie, Paryż, Francja.
• 2012 - Okres szkolenia w zakresie zaawansowanych technologii obrazowania piersi w Centrum Onkologicznym Gustave Roussy, Villejuif, Francja.
• 2009,2011,2013 - Zaktualizowane kursy dotyczące wizualizacji piersi.
• Doświadczenie kliniczne
• 2013 - Dyrektor Departamentu Mammografii, Centrum Medyczne w Tel Awiwie.
• 2007 - Konsultant ds. obrazowania piersi w Maccabi HMO.
• 2005 - Starszy lekarz, Centrum Medyczne Sourasky, Tel Awiw.
• 2000-2005 - Staż w Instytucie Wizualizacji, Centrum Medyczne Sourasky, Tel Awiw.
• 1999-2000 - Staż, Centrum Medyczne Sheba.
• Doświadczenie akademickie
• 2010- Szkolenie z zakresu obrazowania piersi dla studentów medycyny na latach klinicznych, Wydział Obrazowania, Wydział Medycyny, Uniwersytet Tel Awiw.
• 2013 - Wykładowca dla chirurgów stażystów, Szkoła Kształcenia Ustawicznego, Szkoła Medycyny, Uniwersytet Tel Awiw.
• 2000-2005 - Wykładowca w Szkole Radiografii, Centrum Medyczne Sourasky, Tel Awiw, Uniwersytet Bar-Ilan.
• Członkostwo w związkach zawodowych
• Izraelskie Stowarzyszenie Radiologów
• Departament Obrazowania Piersi
• Izraelskie Stowarzyszenie Medyczne
• Północnoamerykańskie Stowarzyszenie Radiologii.
• Obszary szczególnego zainteresowania i działalności
• Biopsja piersi i przedoperacyjne oznakowanie z użyciem MRI.
• Wizualizacja piersi w automatycznym 3D ultradźwięków.
• Usuwanie guzków piersi przy użyciu nieinwazyjnej technologii radiowej (BLES).
• Mammografia z wprowadzeniem środka kontrastowego.
• Molekularne Obrazowanie Piersi, MBI (Molecular Breast Imaging)

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.